Current Biologics Development Projects

Currently active BPN Biologics projects listed on this page have received grant funding, along with expert consultants and CRO (contract research organization) contracts sponsored by NIH. Click on a project to receive more information (abstracts, publications, patents, contacts) via the NIH RePORTER database.

This is a preview of the Data Table. Only the first three rows are displayed.
Title Disorder Modality PI/Lead Investigator Institution
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases Duchenne Muscular Dystrophy Monoclonal antibody Alexis Demonbreun Northwestern University at Chicago
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding Spinal cord injury Peptide Edward Burgard Dignify Therapeutics, LLC
Development of Utrophin Site Blocking Oligos (SBOs) to treat Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy Site blocking oligonuclotide Tejvir S. Khurana University of Pennsylvania
Development of AAV-AIBP for neuroprotecction in glaucoma Glaucoma AAV-encoding protein Wonkyu Ju University of California- San Diego
Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo Syndrome type B Sanfilippo Syndrome Gene Therapy Coy Heldermon University of Florida